Tdspharm
KOE: 464280.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Young Moo Lee
- Employees
- 96
- Headquarters
- Seongnam-si, South Korea
- IPO year
- 2024
- Market cap
- ₩44.6B
- Website
- http://tdspharm.com
Loading 464280…
Loading profile data…Frequently asked questions about 464280
What does Tdspharm (464280.KQ) do?
TDS Pharm Co. Ltd. engages in the development and manufacture of transdermal drug delivery systems. Its products include cataplasma, plasta, fucidin band, and prescription drugs. The company was founded on November 11, 2002 and is headquartered in Seongnam-si, South Korea.
Where does 464280.KQ trade?
Tdspharm (464280.KQ) trades on the KOSDAQ.
What sector is 464280.KQ in?
Tdspharm (464280.KQ) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Tdspharm?
Young Moo Lee is the chief executive officer of Tdspharm (464280.KQ).
Where is Tdspharm headquartered?
Tdspharm is headquartered in South Korea.
Does 464280.KQ pay a dividend?
Tdspharm (464280.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 464280.KQ go public?
Tdspharm (464280.KQ) completed its initial public offering in 2024.